Literature DB >> 17307945

Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection.

Patricia Ngai1, Sarah McCormick, Cherrie Small, Xizhong Zhang, Anna Zganiacz, Naoko Aoki, Zhou Xing.   

Abstract

Gamma interferon (IFN-gamma) is a key cytokine in host defense against intracellular mycobacterial infection. It has been believed that both CD4 and CD8 T cells are the primary sources of IFN-gamma. However, the relative contributions of CD4 and CD8 T-cell subsets to IFN-gamma production and the relationship between CD4 and CD8 T-cell activation have not been examined. By using a model of pulmonary mycobacterial infection and various immunodetection assays, we found that CD4 T cells mounted a much stronger IFN-gamma response than CD8 T cells at various times after mycobacterial infection, and this pronounced IFN-gamma production by CD4 T cells was attributed to both greater numbers of antigen-specific CD4 T cells and a greater IFN-gamma secretion capacity of these cells. By using major histocompatibility complex class II-deficient or CD4-deficient mice, we found that the lack of CD4 T cells did not negatively affect primary or secondary CD8 T-cell IFN-gamma responses. The CD8 T cells activated in the absence of CD4 T cells were capable of immune protection against secondary mycobacterial challenge. Our results suggest that, whereas both CD4 and CD8 T cells are capable of IFN-gamma production, the former represent a much greater cellular source of IFN-gamma. Moreover, during mycobacterial infection, CD8 T-cell IFN-gamma responses and activation are independent of CD4 T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307945      PMCID: PMC1865770          DOI: 10.1128/IAI.00024-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis.

Authors:  Bernadette M Saunders; Anthony A Frank; Ian M Orme; Andrea M Cooper
Journal:  Cell Immunol       Date:  2002 Mar-Apr       Impact factor: 4.868

2.  Enhanced protection against fatal mycobacterial infection in SCID beige mice by reshaping innate immunity with IFN-gamma transgene.

Authors:  Z Xing; A Zganiacz; J Wang; S K Sharma
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

3.  CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection.

Authors:  N V Serbina; V Lazarevic; J L Flynn
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 4.  IFN-gamma production by antigen-presenting cells: mechanisms emerge.

Authors:  D M Frucht; T Fukao; C Bogdan; H Schindler; J J O'Shea; S Koyasu
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

5.  Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.

Authors:  Devon J Shedlock; Jason K Whitmire; Joyce Tan; Andrew S MacDonald; Rafi Ahmed; Hao Shen
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

6.  Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis.

Authors:  Steven C Derrick; Charlene Repique; Philip Snoy; Amy Li Yang; Sheldon Morris
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection.

Authors:  Anna Zganiacz; Michael Santosuosso; Jun Wang; Tony Yang; Lihao Chen; Maria Anzulovic; Scott Alexander; Brigitte Gicquel; Yonghong Wan; Jonathan Bramson; Mark Inman; Zhou Xing
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

8.  Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells.

Authors:  Joanne Turner; Anthony A Frank; Ian M Orme
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

9.  Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses.

Authors:  Mischo Kursar; Kerstin Bonhagen; Joachim Fensterle; Anne Köhler; Robert Hurwitz; Thomas Kamradt; Stefan H E Kaufmann; Hans-Willi Mittrücker
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells.

Authors:  Aaron J Tyznik; Joseph C Sun; Michael J Bevan
Journal:  J Exp Med       Date:  2004-02-09       Impact factor: 14.307

View more
  16 in total

1.  PTPN22 1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients.

Authors:  Yeniley Ruiz-Noa; Jorge Hernández-Bello; Mara A Llamas-Covarrubias; Claudia A Palafox-Sánchez; Edith Oregon-Romero; Pedro Ernesto Sánchez-Hernández; Maria Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Jose Francisco Muñoz-Valle
Journal:  J Clin Lab Anal       Date:  2018-11-06       Impact factor: 2.352

2.  The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice.

Authors:  Dongqing Gu; Wei Chen; Youjun Mi; Xueli Gong; Tao Luo; Lang Bao
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-27       Impact factor: 3.848

3.  Pulmonary mycobacterial granuloma increased IL-10 production contributes to establishing a symbiotic host-microbe microenvironment.

Authors:  Christopher R Shaler; Kapilan Kugathasan; Sarah McCormick; Daniela Damjanovic; Carly Horvath; Cherrie-Lee Small; Mangalakumari Jeyanathan; Xiao Chen; Ping-Chang Yang; Zhou Xing
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

Review 4.  The immunology of tuberculosis: from bench to bedside.

Authors:  Keertan Dheda; Stephan K Schwander; Bingdong Zhu; Richard N van Zyl-Smit; Ying Zhang
Journal:  Respirology       Date:  2010-04       Impact factor: 6.424

5.  EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity.

Authors:  Ran Jing; Irene Scarfo; Mohamad Ali Najia; Edroaldo Lummertz da Rocha; Areum Han; Michael Sanborn; Trevor Bingham; Caroline Kubaczka; Deepak K Jha; Marcelo Falchetti; Thorsten M Schlaeger; Trista E North; Marcela V Maus; George Q Daley
Journal:  Cell Stem Cell       Date:  2022-08-04       Impact factor: 25.269

6.  Immunology of tuberculosis.

Authors:  Qing Zhang; Isamu Sugawara
Journal:  World J Exp Med       Date:  2012-08-20

7.  Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.

Authors:  Frederik Graw; Roland R Regoes
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

Review 8.  T cells in mycobacterial infection and disease.

Authors:  Andrea M Cooper
Journal:  Curr Opin Immunol       Date:  2009-07-29       Impact factor: 7.486

9.  Hydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell Disease.

Authors:  Solo Kuvibidila; Rajasekharan P Warrier; Johnson Haynes; Surendra B Baliga
Journal:  Ochsner J       Date:  2015

10.  Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.

Authors:  Katarina Radosevic; Catharina W Wieland; Ariane Rodriguez; Gerrit Jan Weverling; Ratna Mintardjo; Gert Gillissen; Ronald Vogels; Yasir A W Skeiky; David M Hone; Jerald C Sadoff; Tom van der Poll; Menzo Havenga; Jaap Goudsmit
Journal:  Infect Immun       Date:  2007-05-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.